| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > How Can ISO 9001:2000 be Applied to Healthcare? |
|
Advice You - How Can ISO 9001:2000 be Applied to Healthcare?
Definition of ISO:
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product d that requires an organization to identify, define, document, implement (follow), monitor/measure, and continually improve the effectiveness of its processes. It is a self-directed system that requires the organization to identify and address a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ll imposed requirements; as well as improve its organizational performance by modifying systemic issues (e.g. those traditionally associated with the “hand-offs”). Application of ISO in Healthcare: Using the ISO Family of Stan lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. dards, the organization can establish a comprehensive Quality / Business Management System which:
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe certification & accreditation processes easier and less costly.
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ishment of measurable improvement objectives and accountability to those objectives through monitoring/measuring and reporting.
Structure of the ISO 9001:2000 Standa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rd: The ISO:9001 2000 Standard is comprised of 8 Clauses. The 1st 3 are introductory in nature. The subsequent 5 clauses include the requirements the organization must address. They are:
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ment
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ tion/ Service Operations, Calibration
Internal Audits, Customer/Patient Satisfaction, Monitoring/Measurement of Products/Services and Processes, Handling Nonconformances, Corrective & ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi Preventive Action, Continual Improvement Process / Methodology While the standard does not prescribe the approach or methodology to be utilized by an organization, the following is recommended.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ommitment to support, understanding, involvement, provision of resources
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod y and Map Organizational Processes, key as well as support. Address all imposed requirements.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin , review/revise, and incorporate all required support documentation (e.g. Department Policies/Procedures, forms).
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen >Train internal auditors. Implement an Internal Audit Process.
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s
Sample Key Improvement Objectives
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Percentile
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nt days
Note: Organizational/Hospital-wide objectives are then translated to related departmental, process, individual goals/objectives Sample Process Interaction Diagram See =>. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de onsulting.net/applications-of-iso9001-to-healthcare.html">http://www.iqsconsulting.net/applications-of-iso9001-to-healthcare.html Sample Quality Policy We will strive to be the leading provider of healthcare services in Southern Ohi elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip o. We will accomplish this through tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Bringing the Entrepreneur and the Home Based Business Owner Together Cash Flow Solutions with Factoring
|